Ironwood Retained Earnings from 2010 to 2024

IRWD Stock  USD 6.43  0.05  0.77%   
Ironwood Pharmaceuticals' Retained Earnings are decreasing over the years with slightly volatile fluctuation. Overall, Retained Earnings are projected to go to about -1.6 B this year. Retained Earnings is the cumulative amount of net income that Ironwood Pharmaceuticals retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals
 
Retained Earnings  
First Reported
2008-12-31
Previous Quarter
-1.7 B
Current Value
-1.7 B
Quarterly Volatility
464.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ironwood Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ironwood main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 19.9 M or Total Revenue of 231.7 M, as well as many exotic indicators such as Price To Sales Ratio of 3.82, Dividend Yield of 0.0 or Days Sales Outstanding of 142. Ironwood financial statements analysis is a perfect complement when working with Ironwood Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Ironwood Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Ironwood Pharmaceuticals Technical models . Check out the analysis of Ironwood Pharmaceuticals Correlation against competitors.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.

Latest Ironwood Pharmaceuticals' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Ironwood Pharmaceuticals over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Ironwood Pharmaceuticals' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ironwood Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (1.7 B)10 Years Trend
Slightly volatile
   Retained Earnings   
       Timeline  

Ironwood Retained Earnings Regression Statistics

Arithmetic Mean(1,070,571,950)
Coefficient Of Variation(44.65)
Mean Deviation398,378,353
Median(1,110,115,000)
Standard Deviation478,009,867
Sample Variance228493.4T
Range1.5B
R-Value(0.73)
Mean Square Error113321.3T
R-Squared0.54
Significance0
Slope(78,506,846)
Total Sum of Squares3198908.1T

Ironwood Retained Earnings History

2024-1.6 B
2023-1.7 B
2022-696.4 M
2021-937.6 M
2020-1.5 B
2019-1.6 B
2018-1.6 B

Other Fundumenentals of Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Retained Earnings component correlations

0.70.16-0.16-0.18-0.20.60.60.490.950.20.58-0.280.440.620.650.060.5-0.370.280.650.15
0.70.41-0.780.44-0.180.01-0.04-0.20.75-0.350.250.270.150.00.05-0.07-0.02-0.050.40.910.43
0.160.41-0.480.36-0.46-0.25-0.11-0.250.22-0.07-0.140.190.07-0.27-0.15-0.21-0.27-0.050.530.40.37
-0.16-0.78-0.48-0.790.160.450.460.6-0.290.650.28-0.390.160.480.430.150.45-0.15-0.29-0.79-0.52
-0.180.440.36-0.79-0.13-0.8-0.74-0.74-0.12-0.51-0.710.42-0.08-0.83-0.83-0.05-0.460.370.340.390.19
-0.2-0.18-0.460.16-0.130.01-0.350.06-0.3-0.290.150.4-0.640.01-0.070.690.220.59-0.41-0.290.01
0.60.01-0.250.45-0.80.010.820.890.530.310.79-0.530.150.990.950.140.61-0.39-0.180.110.17
0.6-0.04-0.110.46-0.74-0.350.820.770.560.580.58-0.770.50.850.9-0.20.53-0.71-0.060.09-0.14
0.49-0.2-0.250.6-0.740.060.890.770.340.470.53-0.640.20.880.830.280.69-0.3-0.2-0.130.07
0.950.750.22-0.29-0.12-0.30.530.560.340.10.55-0.250.420.560.6-0.090.25-0.450.320.750.16
0.2-0.35-0.070.65-0.51-0.290.310.580.470.10.21-0.40.760.330.43-0.320.21-0.66-0.06-0.47-0.51
0.580.25-0.140.28-0.710.150.790.580.530.550.21-0.010.10.80.820.050.42-0.31-0.110.170.16
-0.280.270.19-0.390.420.4-0.53-0.77-0.64-0.25-0.4-0.01-0.39-0.54-0.520.12-0.40.530.090.020.22
0.440.150.070.16-0.08-0.640.150.50.20.420.760.1-0.390.170.26-0.560.09-0.760.270.05-0.38
0.620.0-0.270.48-0.830.010.990.850.880.560.330.8-0.540.170.960.140.62-0.41-0.160.10.08
0.650.05-0.150.43-0.83-0.070.950.90.830.60.430.82-0.520.260.96-0.020.53-0.53-0.140.130.1
0.06-0.07-0.210.15-0.050.690.14-0.20.28-0.09-0.320.050.12-0.560.14-0.020.510.74-0.05-0.140.05
0.5-0.02-0.270.45-0.460.220.610.530.690.250.210.42-0.40.090.620.530.510.060.07-0.02-0.11
-0.37-0.05-0.05-0.150.370.59-0.39-0.71-0.3-0.45-0.66-0.310.53-0.76-0.41-0.530.740.060.09-0.120.19
0.280.40.53-0.290.34-0.41-0.18-0.06-0.20.32-0.06-0.110.090.27-0.16-0.14-0.050.070.090.370.03
0.650.910.4-0.790.39-0.290.110.09-0.130.75-0.470.170.020.050.10.13-0.14-0.02-0.120.370.52
0.150.430.37-0.520.190.010.17-0.140.070.16-0.510.160.22-0.380.080.10.05-0.110.190.030.52
Click cells to compare fundamentals

About Ironwood Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ironwood Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Ironwood Pharmaceuticals investors use historical funamental indicators, such as Ironwood Pharmaceuticals's Retained Earnings, to determine how well the company is positioned to perform in the future. Although Ironwood Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Ironwood Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ironwood Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ironwood Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ironwood Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Retained Earnings-1.7 B-1.6 B
Retained Earnings Total Equity-626.7 M-658.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:
Check out the analysis of Ironwood Pharmaceuticals Correlation against competitors.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Ironwood Stock analysis

When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Ironwood Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.69)
Earnings Share
(6.78)
Revenue Per Share
2.647
Quarterly Revenue Growth
(0.28)
Return On Assets
0.0939
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.